Positron-emission tomography (PET) and PET/CT in head and neck cancer - recommendations of an interdisciplinary consensus conference;Positronen-emissionstomografie (PET) und PET/CT bei kopf-hals-tumoren - Ein vorschlag für einen interdisziplinären konsensus

Laryngo- Rhino- Otologie

Volumn 88, Issue 2, 2009, Pages 84-90

  Kohlfürst, Susanne ^a,b   Markitz, M ^c   Raunik, W ^d   Eckel, H E ^c   Kresnik, E ^b   Hausegger, K ^e   Salzwimmer, M ^f   Gaggl, A ^b   Chiari, F ^b   Lind, P ^b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b GENERAL HOSPITAL KLAGENFURT   (Austria)

^c Hals Nasen Ohren Abteilung   (Austria)

^d Abteilung Für Strahlentherapie und Radio Onkologie   (Austria)

^e Abteilung Fur Radiologische Diagnostik   (Germany)

^f MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Diagnostic, therapeutic and follow up impact; F18 FDG PET CT; Head and neck cancer; Interdisciplinary consensus conference

Indexed keywords

ANTINEOPLASTIC AGENT; CONTRAST MEDIUM; FLUORODEOXYGLUCOSE; FLUORODEOXYGLUCOSE F 18; FUROSEMIDE; TRANQUILIZER; DIAGNOSTIC AGENT;

AUSTRIA; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL PRACTICE; CLINICAL PROTOCOL; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; FALSE POSITIVE RESULT; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERDISCIPLINARY RESEARCH; LYMPH NODE METASTASIS; MEDICAL EXPERT; MEDICAL SPECIALIST; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGY; ORAL SURGERY; OTORHINOLARYNGOLOGY; OVERALL SURVIVAL; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RADIOLOGIST; RISK REDUCTION; STEREOTACTIC BODY RADIATION THERAPY; SURGEON; TREATMENT DURATION; TUMOR LOCALIZATION; TUMOR VOLUME; ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER INVASION; COMPUTER ASSISTED RADIOTHERAPY; CONSENSUS; GLUCOSE BLOOD LEVEL; HEAD AND NECK TUMOR; IMAGE PROCESSING; MEGAVOLTAGE RADIOTHERAPY; METABOLISM; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PATIENT CARE; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE;

BLOOD GLUCOSE; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CONSENSUS; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; OTORHINOLARYNGOLOGIC NEOPLASMS; PATIENT CARE TEAM; POSITRON-EMISSION TOMOGRAPHY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, HIGH-ENERGY; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 63149102634     PISSN: 09358943     EISSN: 14388685     Source Type: Journal    
DOI: 10.1055/s-0028-1119439     Document Type: Conference Paper

References (25)

1. Lang S, Wollenberg B, Dellian M, Steuer-Vogt MK, Schwenzer K, Sautier W, Chucholowski M, Eckel R, Faas I, Wilmes E, Ehrenfeld M, Arnold W, Kastenbauer E, Holzel D. Klinische und epidemiologische Daten zu Malignomen des Kopf-Hals-Bereichs. Laryngo-Rhino-Otologie 2002; 81: 499-508 (Pubitemid 34823775)
2. Jackel MC, Rausch H. Fernmetastasierung von Plattenepithelkarzinomen des oberen Aerodigestivtrakts. Der Einfluss klinischer Tumorparameter und des Krankheitsverlaufs. HNO 1999; 47: 38-44
3. Kresnik E, Mikosch P, Gallowitsch HJ, Kogler D, Wieser S, Heinisch M, Unterweger O, Raunik W, Kumnig G, Gomez I, Grunbacher G, Lind P. Evaluation of head and neck cancer with 18-F FDG PET: A comparison with conventional methods. Eur J Nucl Med 2001; 28: 816-821 (Pubitemid 32662543)
4. Lind P, Kresnik E, Kumnig G, Gallowitsch HJ, Igerc I, Matschnig S, Gomez I. 18F-FDG-PET in the follow-up of thyroid cancer. Acta Med Austriaca 2003; 30: 17-21
5. Jungehülsing M, Scheidhauer K, Damm M, Pietrzyk U, Eckel H, Schicha H, Stennert E. 2[F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation. Otolaryngol Head Neck Surg 2000; 123: 294-301
6. Schmidt M, Schmalenbach M, Jungehulsing M, Theissen P, Dietlein M, Schroder U, Eschner W, Stennert E, Schicha H. 18F-FDG PET zum Nachweis von rezidivierenden Kopf-und Hals-Krebs, lokalen Lymphknoten Beteiligung und entfernten Metastasen. Comparison of qualitative visual and semiquantitative analysis. Vergleich der visuellen und qualitativen Analyse semiquantitativ. Nuklearmedizin 2004; 43: 91-101; quiz 102-104
7. Juweid ME, Cheson BD. Positron emission tomography and assessment of cancer therapy. N Engl J Med 2006; 354: 496-507 (Pubitemid 43200300)
8. Reske SN, Kotzerke J. FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "onko-pet III", 21 July and 19 September 2000. Eur J Nucl Med 2001; 28: 1707-1723
9. Beyer T, Townsend DW, Brun T, Kinahan PE, Charron M, Roddy R, Jerin J, Young J, Byars L, Nutt R. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000; 41: 1369-1379 (Pubitemid 30643379)
10. Branstetter BF, Blodgett TM, Zimmer LA, Snyderman CH, Johnson JT, Raman S, Meltzer CC. Head and neck malignancy: Is PET/CT more accurate than PET or CT alone? Radiology 2005; 235: 580-586
11. Fakhry N, Barberet M, Lussato D, Cammilleri S, Mundler O, Giovanni A, Zanaret M. Role of [18F]-FDG PET-CT in the management of the head and neck cancers. Bull Cancer 2006; 93: 1017-1025
12. Schöder H, Carlson DL, Kraus DH, Stambuk HE, Gonen M, Erdi YE, Yeung HW, Huvos AG, Shah JP, Larson SM, Wong RJ. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nucl Med 2006; 47: 755-762 (Pubitemid 46768437)
13. Schöder H, Yeung HW, Gonen M, Kraus D, Larson SM. Head and neck cancer: Clinical usefulness and accuracy of PET/CT image fusion. Radiology 2004; 231: 65-72 (Pubitemid 38375411)
14. Kapoor V, Fukui MB, McCook BM. Role of 18F-FDG PET/CT in the treatment of head and neck cancers: Posttherapy evaluation and pitfalls. AJR Am J Roentgenol 2005; 184: 589-597 (Pubitemid 46657272)
15. Connell CA, Corry J, Milner AD, Hogg A, Hicks RJ, Rischin D, Peters LJ. Clinical impact of, and prognostic stratification by, F-18 FDG PET/CT in head and neck mucosal squamous cell carcinoma. Head Neck 2007; 29: 986-995
16. Hafidh MA, Lacy PD, Hughes JP, Duffy G, Timon CV. Evaluation of the impact of addition of PET/CT and MR scanning in the staging of patients with head and neck carcinomas. Eur Arch Otorhinolaryngol 2006; 263: 853-859 (Pubitemid 44127313)
17. Fakhry N, Lussato D, Jacob T, Giorgi R, Giovanni A, Zanaret M. Comparison between PET and PET/CT in recurrent head and neck cancer and clinical implications. Eur Arch Otorhinolaryngol 2007; 264: 531-538 (Pubitemid 46569959)
18. Fukui MB, Blodgett TM, Meltzer CC. PET/CT imaging in recurrent head and neck cancer. Semin Ultrasound CT MR 2003; 24: 157-163 (Pubitemid 36818819)
19. Avril NE, Weber WA. Monitoring response to treatment in patients utilizing PET. Radiol Clin North Am 2005; 43: 189-204 (Pubitemid 40326568)
20. Dietz A, Nollert J, Eckel H, Volling P, Schroder M, Staar S, Conradt C, Helmke B, Dollner R, Muller RP, Wannenmacher M, Weidauer H, Rudat V. Organerhalt beim fortgeschrittenen Larynx- bzw. Hypopharynxkarzinom durch primäre Radiochemotherapie Ergebnisse einer multizentrischen Phase-II-Studie. HN0 2002; 50: 146-154
21. Ciernik IF, Dizendorf E, Baumert BG, Reiner B, Burger C, Davis JB, Lutolf UM, Steinert HC, Von Schulthess GK. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): A feasibility study. Int J Radiat Oncol Biol Phys 2003; 57: 853-863 (Pubitemid 37194314)
22. Dietl B, Marienhagen J, Kuhnel T, Schaefer C, Kolbl O. FDG-PET in radiotherapy treatment planning of advanced head and neck cancer - a prospective clinical analysis. Auris Nasus Larynx 2006; 33: 303-309 (Pubitemid 43867212)
23. Gregoire V, Bol A, Geets X, Lee J. Is PET-based treatment planning the new standard in modern radiotherapy? The head and neck paradigm. Semin Radiat Oncol 2005; 16: 232-238 (Pubitemid 44436964)
24. Gregoire V, Haustermans K, Geets X, Roels S, Lonneux M. PET-based treatment planning in radiotherapy: A new standard? J Nucl Med 2007; 48 Suppl 1: 68S-77S
25. Koshy M, Paulino AC, Howell R, Schuster D, Halkar R, Davis LW. F-18 FDG PET/CT fusion in radiotherapy treatment planning for head and neck cancer. Head Neck 2005; 27: 494-502 (Pubitemid 40770818)